PS Stock Downgraded: Is Pershing Square Overvalued After 150% Rally?
💡 Key Takeaway
Pershing Square's post-IPO rally has left the stock overvalued at 54x forward earnings, prompting downgrades from Citi and BofA; investors should tread carefully despite potential long-term catalysts.
Citi and BofA Downgrade PS Stock on Valuation Concerns
Pershing Square Inc. (PS), the investment firm led by Bill Ackman, went public in April at $24 per share and quickly became a market darling, surging 150% to a peak of $60 by October 7. However, the stock has since plummeted about 25% to around $45, following two major Wall Street downgrades.
Last week, Citi downgraded PS from neutral to sell, maintaining a $45 price target. The analysts flagged the stock's rich valuation at 54 times forward earnings and lowered their 2027 earnings estimate to $0.89 per share from $1.01, citing tepid investment performance at Pershing Square's funds, including Pershing Square Holdings and Pershing Square USA.
This week, BofA followed suit, downgrading PS to underperform and cutting its price target from $54 to $38, implying a 15% decline over the next year. BofA echoed concerns about high valuation amid modest or negative returns, noting that Pershing Square's revenue is heavily tied to investment management fees, which decline when asset levels drop.
Despite the downgrades, Pershing Square has several irons in the fire. It plans to launch Pershing Square Ventures, a private equity fund targeting pre-IPO stocks, by the end of 2026. Additionally, its controlling stake in Howard Hughes Holdings (HHH) could be a hidden gem: HHH recently acquired specialty insurer Vantage Group Holdings, and Ackman envisions it as a 'modern-day Berkshire Hathaway' using insurance float to invest in other assets. Citi cited this as a potential upside catalyst.
Valuation Concerns Could Cap Near-Term Upside
The downgrades highlight a classic dilemma: a hot IPO that has run too far, too fast. At 54 times forward earnings, PS stock prices in a lot of optimism, leaving little room for disappointment. The reduced earnings estimates reflect the reality that Pershing Square's core business—managing funds—is subject to market whims, and with uncertain markets ahead, fee income could be pressured.
For investors, the key question is whether the growth story justifies the premium. While the planned Pershing Square Ventures fund and the Howard Hughes 'Berkshire Hathaway' strategy offer long-term potential, they are unlikely to contribute meaningfully to earnings in the near term. Citi's $45 target suggests the stock is fairly valued at best, while BofA's $38 target implies downside.
The market's reaction—a 25% drop from the peak—signals that investors are reassessing the risk-reward. As a newly public company, Pershing Square also lacks a long track record, which adds to the uncertainty. The stock could remain volatile as analysts and investors digest the valuation and the company's ability to grow assets under management.
Source: The Motley Fool
Analysis generated by Bobby AI quantitative model, reviewed and edited by our research team. This is not financial advice. Always do your own research before making investment decisions.
Bobby Insight
Avoid PS stock for now; wait for a better entry point as valuation concerns and downgrades weigh on the shares.
The stock's lofty valuation (54x forward earnings) leaves little margin of safety, and the downgrades by Citi and BofA reflect growing skepticism about near-term growth. While long-term initiatives like Pershing Square Ventures and the Howard Hughes strategy are promising, they are unlikely to offset current headwinds. Investors should wait for a more attractive valuation or clearer signs of earnings acceleration before buying.
What This Means for Me
